2,785 reports of this reaction
16.0% of all TAFAMIDIS reports
#1 most reported adverse reaction
DEATH is the #1 most commonly reported adverse reaction for TAFAMIDIS, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 2,785 FDA adverse event reports linking TAFAMIDIS to DEATH. This represents approximately 16.0% of all 17,433 adverse event reports for this drug.
Patients taking TAFAMIDIS who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a frequently reported adverse event for TAFAMIDIS, accounting for a significant proportion of all reports.
In addition to death, the following adverse reactions have been reported for TAFAMIDIS:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 2,785 FDA reports for TAFAMIDIS. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 16.0% of all adverse event reports for TAFAMIDIS, making it one of the most commonly reported side effect.
If you experience death while taking TAFAMIDIS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.